WHO ICTRP trial
Effect of dutasteride versus placebo on the treatment of patients with Lichen…
IRCT20120215009014N568 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20120215009014N568 |
|---|---|
| Public title | Effect of dutasteride versus placebo on the treatment of patients with Lichen Planopilaris |
| Scientific title | Effect of oral dutasteride versus placebo combined with topical clobetasol and minoxidil on the treatment of patients with Lichen Planopilaris: a double-blind randomized clinical trial |
| Primary sponsor | Hamedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Lichen Planopilaris. Lichen planopilaris;L66.1 |
| Interventions | Intervention 1: Intervention group: Topical treatment with clobetasol lotion (Made by Abu Raihan Pharmaceutical Company) once a night and minoxidil lotion (Made by Nano Pharmed Pharmaceutical Company) twice a day plus oral treatment with… |
| Registration date | Aug 12, 2025 |
| Target size | 122 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: